InvestorsHub Logo

Tal10

03/31/21 2:49 PM

#332386 RE: biopa #332381

Wall Street could care less about "possibilities" when it comes to Amarin. All they want to see are sales. And Thero is failing miserably in getting doctors excited to prescribe this drug to their patients.